Evaluation of routine care of prurigo nodularis in Germany: retrospective chart review study (ADVANCE PN)

Background and Objectives Knowledge on patient care gaps of prurigo nodularis (PN) is limited. This retrospective chart review (ADVANCE PN) investigated unmet medical needs and gaps in diagnostics, treatment, and management of patients with PN in routine care in Germany. Patients and Methods Medical...

Full description

Saved in:
Bibliographic Details
Main Authors: Kiedrowski, Ralph von (Author) , Metz, Martin (Author) , Weisshaar, Elke (Author) , Albrecht, Inka (Author) , Schild, Marie (Author) , Ständer, Sonja (Author)
Format: Article (Journal)
Language:English
Published: July 2025
In: Journal der Deutschen Dermatologischen Gesellschaft
Year: 2025, Volume: 23, Issue: 7, Pages: 844-855
ISSN:1610-0387
DOI:10.1111/ddg.15721
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1111/ddg.15721
Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/ddg.15721
Get full text
Author Notes:Ralph von Kiedrowski, Martin Metz, Elke Weisshaar, Inka Albrecht, Marie Schild, Sonja Ständer
Description
Summary:Background and Objectives Knowledge on patient care gaps of prurigo nodularis (PN) is limited. This retrospective chart review (ADVANCE PN) investigated unmet medical needs and gaps in diagnostics, treatment, and management of patients with PN in routine care in Germany. Patients and Methods Medical records for adults newly diagnosed with PN between January 2012 and December 2022 from dermatologic clinics and office-based dermatologists were analyzed. Baseline demographics, treatment patterns, diagnostics, symptoms, patient-reported outcomes (PROs), and disease-specific scores are reported. Results Records of 363 patients from 42 sites were analyzed. Median age (range) was 67 (19-95) years; most patients were female (61.7%), Caucasian (73.4%), and retired (57.3%). Overall, 209 (62.2%) patients had comorbidities (most common: hypertension [28.3%]). Clinically, most patients had nodules (81.1%) or papules (66.7%). PROs, disease-specific scores, and laboratory assessments were performed for 32 (8.8%), 12 (3.3%), and 71 (19.7%) patients, respectively. Topical corticosteroids (TCS) were the most common overall (90.9%) and first-line therapy (84.9%); for second-line therapy, ‘no further treatment’ was most commonly documented (58.6%). Conclusions The findings of ADVANCE PN indicate a high unmet need in the current state of medical care, evidenced by shortcomings in PRO assessment, PN documentation, and adherence to guidelines on PN.
Item Description:Zuerst veröffentlicht: 08. Juni 2025
Gesehen am 17.09.2025
Physical Description:Online Resource
ISSN:1610-0387
DOI:10.1111/ddg.15721